PT Diagnos Laboratorium Utama Tbk (IDX:DGNS)
Indonesia flag Indonesia · Delayed Price · Currency is IDR
232.00
+4.00 (1.75%)
May 26, 2026, 4:00 PM WIB

IDX:DGNS Balance Sheet

Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
6,1138,4754,20910,24528,01144,720
Short-Term Investments
1,4581,458959.591,6962,5436,507
Cash & Short-Term Investments
7,5719,9335,16911,94130,55351,227
Cash Growth
19.39%92.17%-56.71%-60.92%-40.36%209.75%
Accounts Receivable
44,43546,27641,81038,28042,42241,730
Other Receivables
8,21510,4277,0796,9727,03332,209
Receivables
52,65056,70348,88945,25249,45573,939
Inventory
7,1686,0795,0435,1426,5677,760
Prepaid Expenses
26,120357.75275.79194.89266.08784.92
Other Current Assets
-18,12519,23125,27531,53220,153
Total Current Assets
93,50991,19878,60887,805118,373153,864
Property, Plant & Equipment
207,149209,420202,426164,248109,21987,107
Long-Term Investments
12,95112,95112,95112,9518,445-
Other Intangible Assets
1,6891,6701,353720.43681.12-
Long-Term Deferred Tax Assets
697.72697.72815.571,0311,0201,012
Other Long-Term Assets
2,7362,7363,8694,7192,198-
Total Assets
318,731318,672300,022271,475239,936241,983
Accounts Payable
12,9158,9219,5516,0903,0784,524
Accrued Expenses
4,8366,4464,1163,1781,5563,125
Current Portion of Long-Term Debt
6,2512,612152.08-1,701-
Current Portion of Leases
4,4364,3945,0123,7101,8112,390
Current Income Taxes Payable
646.1153.71255.12268.87674.8316,013
Current Unearned Revenue
2,9564,7781,748651.53893.77-
Other Current Liabilities
288.63310.34772.59545.72777.24576.26
Total Current Liabilities
32,33027,61521,60614,44410,49226,628
Long-Term Debt
49,35049,50844,81730,0009,358-
Long-Term Leases
18,05120,63220,40121,004409.042,888
Long-Term Unearned Revenue
6,5456,8007,820---
Pension & Post-Retirement Benefits
1,6381,5481,2922,1561,6863,103
Other Long-Term Liabilities
8,1438,5787,9548,2807,5637,563
Total Liabilities
116,057114,682103,89075,88529,50840,182
Common Stock
31,25031,25031,25031,25031,25031,250
Additional Paid-In Capital
36,70736,70736,70736,70736,70736,707
Retained Earnings
133,886135,202132,265131,518145,173132,509
Comprehensive Income & Other
831.26831.26-4,090-3,884-2,7021,335
Shareholders' Equity
202,674203,990196,132195,590210,428201,800
Total Liabilities & Equity
318,731318,672300,022271,475239,936241,983
Total Debt
78,08877,14670,38254,71413,2795,277
Net Cash (Debt)
-70,517-67,214-65,213-42,77317,27445,950
Net Cash Growth
-----62.41%229.33%
Net Cash Per Share
-56.38-53.77-52.17-34.2213.8237.04
Filing Date Shares Outstanding
1,2501,2501,2501,2501,2501,250
Total Common Shares Outstanding
1,2501,2501,2501,2501,2501,250
Working Capital
61,17963,58257,00273,361107,881127,236
Book Value Per Share
162.14163.19156.91156.47168.34161.44
Tangible Book Value
200,985202,320194,779194,870209,747201,800
Tangible Book Value Per Share
160.79161.86155.82155.90167.80161.44
Land
-60,80254,64343,65543,65543,655
Buildings
-82,773----
Machinery
-48,58646,44744,28539,54831,771
Construction In Progress
-13,62788,00153,06118,411311.4
Leasehold Improvements
-27,72127,85726,02623,67214,201
Source: S&P Global Market Intelligence. Standard template. Financial Sources.